Homeopathy in the discontinuation of inhaled corticosteroid during the treatment of teenagers with perennial asthma

Phase 2

• Conditions: Perennial asthma; C08.127.108

• Registration Number: RBR-6xts8z
• Lead Sponsor: niversidade Federal de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-05-06
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Subjects with diagnosis of perennial asthma; using inhalatory beclometasone; presenting
dyspnea; and or tightness in the chest; and or cough; and or effort dyspnea; and or other atopic diseases, such as rhinitis, conjunctivitis, dermatitis.

Exclusion Criteria

Severe perennial asthma presenting exacerbations requiring hospital admission or systemic medication

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome is the number of days of good clinical control during the reduction of inhaled corticotherapy. Expected outcome is a significantly greater mean in the group randomized to continue with Homeopathy group, as compared to placebo.

Secondary Outcome Measures

Name	Time	Method
umber (mean) of days of bronchodilator (B2-agonists) use; moderate exacerbations (defined as use of an emergency room not resulting in hospital admission); patients excluded due to asthma exacerbation indicating poor clinical control; adverse events.<br>Expected outcome are significantly lower means in the group randomized to continue with Homeopathy group, as compared to placebo.